Using germline variants to estimate glioma and subtype risks-Reference-Cited by-同舟云学术

Using germline variants to estimate glioma and subtype risks

Published:2019-01-08 Issue:4 Volume:21 Page:451-461
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Eckel-Passow Jeanette E¹,Decker Paul A¹,Kosel Matt L¹,Kollmeyer Thomas M²,Molinaro Annette M³⁴,Rice Terri³,Caron Alissa A²,Drucker Kristen L²,Praska Corinne E²,Pekmezci Melike⁵,Hansen Helen M³,McCoy Lucie S³,Bracci Paige M⁴,Erickson Bradley J⁶,Lucchinetti Claudia F⁷,Wiemels Joseph L⁸,Wiencke John K³⁴⁹,Bondy Melissa L¹⁰,Melin Beatrice¹¹,Burns Terry C¹²,Giannini Caterina²,Lachance Daniel H²⁷,Wrensch Margaret R³⁴⁹,Jenkins Robert B²

Affiliation:

1. Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, Minnesota, USA

2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

3. Department of Neurological Surgery, University of California San Francisco (UCSF), San Francisco, California, USA

4. Department of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA

5. Department of Pathology, UCSF, San Francisco, California, USA

6. Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA

7. Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA

8. Center for Genetic Epidemiology, University of Southern California, Los Angeles, California, USA

9. Institute of Human Genetics, UCSF, San Francisco, California, USA

10. Department of Medicine, Baylor College of Medicine, Houston, Texas, USA

11. Department of Radiation Sciences, Faculty of Medicine, Umeå University, Umeå, Sweden

12. Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/21/4/451/28085752/noz009.pdf

Reference48 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012;Ostrom;Neuro Oncol.,2015

2. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors;Eckel-Passow;N Engl J Med,2015

3. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;Brat;N Engl J Med.,2015

4. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma;Ceccarelli;Cell,2016

5. Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas;Killela;Oncotarget,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics biomarker selection and outlier detection across WHO glioma classifications via robust sparse multinomial regression;2024-08-26

2. Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomas;2024-07-17

3. Co-expression in tissue-specific gene networks links genes in cancer-susceptibility loci to known somatic driver genes;BMC Medical Genomics;2024-07-15

4. Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes;Neuro-Oncology;2024-06-25

5. Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes;2024-01-11